63-year-old male with AML and recent bacteremia and liver lesions on MRI and July. CT in August showed resolving lesions. We would like a confirmation. ABDOMEN:LIVER, BILIARY TRACT: Multiple enhancing lesions scattered through the liver have decreased in size in the interval. The previously described segment 6 lesion is no longer visualized on postcontrast imaging. The largest lesion in segment 5 measures 1.7 x 1.8 cm (axial series 1402 image 55), and this lesion measured 1.5 x 3.3 cm on the 7/28/2016 exam. An additional small subcentimeter enhancing lesion in the anterior-inferior right hepatic lobe (axial series 1402 image 23) has also decreased in size in the interval.Normal liver contour. The diffuse T2 hypointensity of the liver and spleen is compatible with hemosiderosis.SPLEEN: T2 hypointense signal is compatible with hemosiderosis.PANCREAS: No significant abnormality noted.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: No significant abnormality noted.RETROPERITONEUM, LYMPH NODES: No significant abnormality noted.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: Diffuse T2 hypointense signal intensity compatible with hemosiderosis.OTHER: Bilateral pleural effusions.
1.The previously described largest lesion of hepatic segment 6 has resolved. The other known enhancing hepatic lesions have decreased in size.2.Diffuse T2 hypointense signal intensity of the liver, spleen, and bone marrow are compatible with hemosiderosis.